No. The NYU dementia study does not promise that any person will gain 13 extra years.
It found an observational association—a pattern between groups, not proof that changing three risks will delay dementia by 13 years. The "13 years" compares average dementia-free time for midlife groups with none versus all three measured risks: high blood pressure, diabetes, and smoking. It is a population estimate, not a guarantee, treatment result, or individual prediction.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the NYU study actually compared
- Why an association is not a promise
- What "dementia-free years" includes
- Who can use the finding—and how cautiously?
What the NYU study actually compared
The study used data from 12,409 U.S. adults who were dementia-free at an average age of 56. Participants were followed for an average of 26 years, according to the American Academy of Neurology report. Researchers grouped participants by whether they had three measured midlife risks: People with none of the measured risks averaged about 30 dementia-free years after baseline.
Those with all three averaged about 17 years. The roughly 13-year figure is the difference between those group averages. That comparison does not show that removing one risk produces a fixed number of additional years. It compares two ends of a risk profile, while many participants fell between them and people differ in other important ways.
- High blood pressure
- Diabetes
- Smoking
Why an association is not a promise
nyu Langone Health reported that the research was observational and was not designed to establish causation NYU Langone Health's study summary. In an observational study, researchers measure patterns in existing groups rather than assigning people to treatments. The groups may differ in ways the analysis did not fully measure. Those unmeasured differences could have contributed to the gap, even though the study found an association between the three risks and dementia-free time.
The study also measured the three risk factors only once. It therefore cannot show what happens to one person who later stops smoking, controls blood pressure, develops diabetes, or changes treatment over time. That limitation matters for decision-making. The study supports taking these risks seriously, but it does not support the calculation, "If I change one factor, I will gain 13 years.".
What "dementia-free years" includes
"dementia-free years" does not mean extra years of life. It means time before either dementia was diagnosed or the person died without dementia. During follow-up, 3,008 participants developed dementia and 5,238 died without dementia, according to the American Academy of Neurology report.
Death affects the estimate because a person who dies without dementia no longer contributes additional dementia-free follow-up time. This makes the headline easy to misunderstand. The result does not show that avoiding the three risks cures dementia, prevents every case, or extends lifespan by 13 years. A more accurate reading is: in this cohort, people with none of the measured risks had a longer average period before dementia or death than people with all three.
Who can use the finding—and how cautiously?
The estimate best describes population groups resembling the study participants: U.S. adults who were dementia-free around midlife and then followed for decades. It cannot predict when a particular reader will develop dementia or whether that reader will develop it at all. The headline also hides differences among groups. Among participants with all three risks, women averaged 18.1 dementia-free years, compared with 16.6 years for men.
White participants averaged 19.6 years, compared with 16.0 years for Black participants. Those differences do not produce a personal forecast either. They show why one headline number cannot represent every person's risk, health history, access to care, or likely outcome. A practical use of the study is to treat high blood pressure, diabetes, and smoking as issues worth discussing with a healthcare professional, especially during midlife. The useful question is not "How do I claim 13 extra years?" but "Which risk factors do I have, and what change is appropriate for me?".
